Accuray (ARAY) Profit After Tax (QoQ) (2010 - 2026)
Accuray (ARAY) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Accuray | 37.50 Mn | -2.20 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.95% |
| Dec 31, 2025 | 36.48% |
| Sep 30, 2025 | -2,541.22% |
| Jun 30, 2025 | 124.34% |
| Mar 31, 2025 | -146.71% |
| Dec 31, 2024 | 297.57% |
| Sep 30, 2024 | -2,571.62% |
| Jun 30, 2024 | 99.30% |
| Mar 31, 2024 | -121.00% |
| Dec 31, 2023 | -224.05% |
| Sep 30, 2023 | -437.77% |
| Jun 30, 2023 | 113.07% |
| Mar 31, 2023 | -258.80% |
| Dec 31, 2022 | 65.61% |
| Sep 30, 2022 | -624.60% |
| Jun 30, 2022 | 73.00% |
| Mar 31, 2022 | -284.32% |
| Dec 31, 2021 | 163.20% |
| Sep 30, 2021 | -245.02% |
| Jun 30, 2021 | -114.49% |